Covestor’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
Other funds holding FDMT
Covestor's FDMT Position: Q3 2026 in Review
Covestor sold out of 4D Molecular Therapeutics (FDMT) in Q3 2026, closing a stake of 34 shares.
Covestor first reported a position in FDMT in Q1 2024 and held it in 10 quarters. The position peaked at $0 in Q2 2026. 110 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.
- Covestor reported no remaining 4D Molecular Therapeutics position as of Q3 2026 after selling out during the quarter.
- Covestor sold 34 4D Molecular Therapeutics shares in Q3 2026.
- Covestor first reported a position in 4D Molecular Therapeutics in Q1 2024 and held it in 10 quarters.
- Covestor's 4D Molecular Therapeutics position peaked at $0 in Q2 2026.
- 110 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.